Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Amivantamab
Amivantamab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
Rybrevant 350 mg concentrate for solution for infusion
Updated
SPC
PIL
No
A
Amivantamab
Janssen Sciences Ireland (a Johnson & Johnson Company)
Cookies